Malabar Organics Ltd

Malabar Organics Ltd

Produces synthetic bulk drugs and intermediates, pharmaceuticals, medicals, chemicals, and surgical equipment.
1986 | Koyilandy, Kerala (India) | Under Liquidation

Last Updated:

April 27, 2024
HomeCompanyMalabar Organics Ltd

Who are the key members and board of directors at Malabar Organics?

Executive Team (1)

NameDesignationAppointment DateStatus
Vijayan Arikkath InManaging Director10-Oct-1988Current

Board Members(2)

NameDesignationAppointment DateStatus
Gopalan Meethal In Director 13-Feb-1992Current
Maniamkode Vijayapadman In Director 10-Oct-1988Current

Financial Performance and Corporate Structure Insights of Malabar Organics.

Malabar Organics Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 35.66% increase. The company also saw a substantial fall in profitability, with a 6027.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.33%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
35.66%
Revenue from Operations
Total Assets
-5.26%
Profit or Loss
-6027.65%
Net Worth
-25.33%
EBITDA
-723.95%

Related Corporates (Common Directorship)

Charges (Loans)

Satisfied Charges

₹1.58 Cr

LenderAmountStatus

Vijaya Bank

Creation Date: 09 Apr 1992
₹2.30 MSatisfied

Kerala State Industrial Development Corporation Limited

Creation Date: 08 Apr 1992
₹7.50 MSatisfied

Kerala Financial Corporation

Creation Date: 08 Apr 1992
₹6.00 MSatisfied

How Many Employees Work at Malabar Organics?

Unlock and access historical data on people associated with Malabar Organics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Malabar Organics

Recent activity within the organization

  • Annual General Meeting

    Malabar Organics Ltd last Annual general meeting of members was held on 27 Aug 2022 as per latest MCA records.

    27 Aug 2022

  • Balance Sheet

    Malabar Organics Ltd has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ernakulam.

    31 Mar 2022

  • Charges

    A charge registered on 09 Apr 1992 via Charge ID 80054474 with Vijaya Bank was fully satisfied on 08 Mar 2011.

    08 Mar 2011

  • Charges

    A charge registered on 08 Apr 1992 via Charge ID 80054473 with Kerala Financial Corporation was fully satisfied on 11 Jan 2011.

    11 Jan 2011

  • Charges

    A charge registered on 08 Apr 1992 via Charge ID 80054472 with Kerala State Industrial Development Corporation Limited was fully satisfied on 01 Jul 2009.

    01 Jul 2009

  • Charges

    A charge with Vijaya Bank of Rs. 0.23 Cr registered on 09 Apr 1992 with Charge ID 80054474 was modified on 27 May 1992.

    27 May 1992

Frequently asked questions

  • Malabar Organics Ltd was incorporated on 16 Oct 1986.

  • The authorized share capital of Malabar Organics Ltd is ₹ 5.00 Cr and paid-up capital is ₹ 2.38 Cr.

  • Currently 3 directors are associated with Malabar Organics Ltd.

    • Gopalan Ambalathil Meethal
    • Vijayan Arikkath
    • Maniamkode Jinachandran Vijayapadman
  • As per Ministry of Corporate Affairs (Mca), the registered address of Malabar Organics Ltd is 13/334 Hill Bazar, Moodadi North, Koyilandy, Kerala, India, 673325.

  • The corporate identification number (CIN) of Malabar Organics Ltd is U24119KL1986PLC004576 and the company number is 004576 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2022, the revenue trend for Malabar Organics Ltd has risen by 35.66%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Malabar Organics Ltd has experienced an downturn of -25.33%.

  • The most recent Balance Sheet for Malabar Organics Ltd was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Drug Formulation & Development